Cargando…
Non-neutralizing antibodies increase endogenous circulating Ang1 levels
Ang1 is a soluble ligand to receptor Tie2, and increasing the circulating Ang1 level may improve vascular stabilization under certain disease conditions. Here, we found that the circulating Ang1 level was significantly increased in cynomolgus monkeys treated with non-neutralizing anti-Ang1 antibodie...
Autores principales: | Zheng, Chao, Toth, Joshuaine, Bigwarfe, Tammy, MacDougall, Margit, Jerath, Kavita, Bovat, Kristin, Smith, James, Sun, Peng, Hayes, David, Fryer, Ryan, Singh, Sanjaya, Kroe-Barrett, Rachel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6284558/ https://www.ncbi.nlm.nih.gov/pubmed/30199300 http://dx.doi.org/10.1080/19420862.2018.1521130 |
Ejemplares similares
-
VHH antibody targeting the chemokine receptor CX3CR1 inhibits progression of atherosclerosis
por: Low, Sarah, et al.
Publicado: (2020) -
Maximizing in vivo target clearance by design of pH-dependent target binding antibodies with altered affinity to FcRn
por: Yang, Danlin, et al.
Publicado: (2017) -
IgG Charge: Practical and Biological Implications
por: Yang, Danlin, et al.
Publicado: (2019) -
IgG cooperativity – Is there allostery? Implications for antibody functions and therapeutic antibody development
por: Yang, Danlin, et al.
Publicado: (2017) -
Efficient Qualitative and Quantitative Determination of Antigen-induced Immune Responses
por: Yang, Danlin, et al.
Publicado: (2016)